Literature DB >> 19491301

Clinical utility of ANA measured by ELISA compared with ANA measured by immunofluorescence.

Gerald A Maguire, Amel Ginawi, Jeffrey Lee, Anita Y N Lim, Graham Wood, Sally Houghton, Dinakantha S Kumararatne, Hill J S Gaston.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19491301     DOI： 10.1093/rheumatology/kep137

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  6 in total

1.  Frequency and specificity of antibodies against nuclear and cytoplasmic antigens in healthy individuals by classic and new methods.

Authors:  E Giannouli; D Chatzidimitriou; S Gerou; E Gavriilaki; L Settas; E Diza
Journal:  Clin Rheumatol       Date:  2013-05-11       Impact factor: 2.980

2.  How should a district general hospital immunology service screen for anti-nuclear antibodies? An 'in-the-field' audit.

Authors:  R Hira-Kazal; P Shea-Simonds; J L Peacock; J Maher
Journal:  Clin Exp Immunol       Date:  2015-04       Impact factor: 4.330

3.  THYROTROPIN-RECEPTOR ANTIBODIES, IMMUNOGLOBULIN E AND ANTINUCLEAR ANTIBODIES IN PATIENTS WITH GRAVES' DISEASE AND GRAVES' ORBITOPATHY.

Authors:  M Stoynova; A Shinkov; G Kirilov; R Kovatcheva
Journal:  Acta Endocrinol (Buchar)       Date:  2021 Apr-Jun       Impact factor: 0.877

4.  Antinuclear antibody testing: discordance between commercial laboratories.

Authors:  Aryeh M Abeles; Manuel Gomez-Ramirez; Micha Abeles; Shyoko Honiden
Journal:  Clin Rheumatol       Date:  2016-04-05       Impact factor: 2.980

Review 5.  Protein microarrays: a new tool for the study of autoantibodies in immunodeficiency.

Authors:  Jacob M Rosenberg; Paul J Utz
Journal:  Front Immunol       Date:  2015-04-07       Impact factor: 7.561

Review 6.  Current concepts and future directions for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies.

Authors:  Michael Mahler; Pier-Luigi Meroni; Xavier Bossuyt; Marvin J Fritzler
Journal:  J Immunol Res       Date:  2014-04-27       Impact factor: 4.818
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.